Get Help Sign In


IDT signs contract to supply Research Councils UK with custom oligonucleotides

Feb 17, 2011

Three year deal to advance UK scientific research

CORALVILLE, IA - July 12th 2010. Integrated DNA Technologies (IDT), the world leader in oligonucleotide synthesis, has signed a three year contract with Research Councils UK (RCUK) for the supply of synthetic oligonucleotides. RCUK coordinates the UK’s seven research councils, enhancing the overall impact and effectiveness of the research they fund. As one of the preferred suppliers of custom oligonucleotides, IDT’s expert production technologies will aid RCUK in delivering on the UK government’s objectives for science and innovation.

Each year RCUK invests approximately £2.5 billion in research, covering a broad spectrum of academic disciplines from medical and biological sciences, to astronomy, physics and chemistry. “We are delighted to name IDT as one of our preferred suppliers of custom oligonucleotides” commented Richard Fowles, Category Manager, RCUK. He continued, “IDT’s advanced manufacturing capabilities will provide the scientists we fund with a broad range of synthetic oligos to cover all of their requirements.”

“It is fantastic news that we have been selected as a preferred supplier by RCUK. We want researchers in the UK to benefit from IDT’s twenty-year commitment to tireless innovation and peerless quality in oligo synthesis. We can also use this opportunity to learn how IDT can best support research worldwide, as the science and application of synthetic biology advances,” commented Dr. Joseph A. Walder, IDT’s founder and CEO. With the ability to provide a complete range of oligos, from basic sequences to Ultramers, IDT offers the high fidelity synthesis of very long oligos up to 200 bases. Furthermore, proprietary synthesis systems and chemistries enable complete customization with any required modification(s).

IDT also provides a number of other molecular biology reagents, including custom synthetic genes and the free online SciTools, which provide all of the functionality required by scientists to optimize their oligo sequences.


Learn about IDT's role in the fight against COVID-19

Media and PR

For media inquiries please contact IDT Public Relations,